Literature DB >> 22761219

Chronic acetaminophen ingestion resulting in severe anion gap metabolic acidosis secondary to 5-oxoproline accumulation: an under diagnosed phenomenon.

L Morgan Nordstrom O'Brien1, Michael Hooper, Mark Flemmer, Paul Ellis Marik.   

Abstract

Anion gap metabolic acidosis is commonly caused by lactic acidosis, ketoacidosis, and ingestion of methanol, salicylates, ethylene glycol or accumulation of organic/inorganic acids. However, rare causes of metabolic acidosis from enzyme defects, such as disturbances in the γ-glutamyl cycle, are being reported in higher frequencies in the adult population. Such disturbances cause an accumulation of 5-oxoproline and ultimately an anion gap metabolic acidosis. These disturbances are often associated with acetaminophen in the setting of certain risk factors such as sepsis, malnutrition, liver disease, female gender, pregnancy or renal failure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22761219      PMCID: PMC3391392          DOI: 10.1136/bcr.03.2012.6020

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Profound metabolic acidosis from pyroglutamic acidemia: an underappreciated cause of high anion gap metabolic acidosis.

Authors:  Thomas J Green; Jan Jaap Bijlsma; David D Sweet
Journal:  CJEM       Date:  2010-09       Impact factor: 2.410

2.  5-oxoproline-induced anion gap metabolic acidosis after an acute acetaminophen overdose.

Authors:  David T Lawrence; Laura K Bechtel; Nathan P Charlton; Christopher P Holstege
Journal:  J Am Osteopath Assoc       Date:  2010-09

3.  Glutathione S-transferases of mouse liver: sex-related differences in the expression of various isozymes.

Authors:  S S Singhal; M Saxena; H Ahmad; Y C Awasthi
Journal:  Biochim Biophys Acta       Date:  1992-04-22

Review 4.  The gamma-glutamyl cycle. Diseases associated with specific enzyme deficiencies.

Authors:  A Meister
Journal:  Ann Intern Med       Date:  1974-08       Impact factor: 25.391

5.  Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis.

Authors:  G A Dempsey; H J Lyall; C F Corke; C D Scheinkestel
Journal:  Crit Care Med       Date:  2000-06       Impact factor: 7.598

6.  5-oxoprolinemia causing elevated anion gap metabolic acidosis in the setting of acetaminophen use.

Authors:  Patil Armenian; Roy R Gerona; Paul D Blanc; Alan H B Wu; Somnath Mookherjee
Journal:  J Emerg Med       Date:  2011-10-05       Impact factor: 1.484

7.  Unexplained metabolic acidosis in critically ill patients: the role of pyroglutamic acid.

Authors:  Barry A Mizock; Stanislav Belyaev; Carter Mecher
Journal:  Intensive Care Med       Date:  2003-12-19       Impact factor: 17.440

Review 8.  Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen.

Authors:  Andrew Z Fenves; Haskell M Kirkpatrick; Viralkumar V Patel; Lawrence Sweetman; Michael Emmett
Journal:  Clin J Am Soc Nephrol       Date:  2006-04-19       Impact factor: 8.237

9.  Transient 5-oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects.

Authors:  J J Pitt; S Hauser
Journal:  Clin Chem       Date:  1998-07       Impact factor: 8.327

  9 in total
  3 in total

Review 1.  Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): a tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle.

Authors:  Michael Emmett
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

2.  Pyroglutamic acidosis by glutathione regeneration blockage in critical patients with septic shock.

Authors:  Yenifer Gamarra; Felipe C Santiago; Jorge Molina-López; José Castaño; Lourdes Herrera-Quintana; Álvaro Domínguez; Elena Planells
Journal:  Crit Care       Date:  2019-05-07       Impact factor: 9.097

Review 3.  Severe Anion Gap Metabolic Acidosis Resulting from Combined Chronic Acetaminophen Toxicity and Starvation Ketosis: A Case Report and Literature Review.

Authors:  Thomas Kalinoski
Journal:  Am J Case Rep       Date:  2022-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.